Patents by Inventor Socheata Ly

Socheata Ly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OLIGONUCLEOTIDES FOR SARS-CoV-2 MODULATION
    Publication number: 20240425860
    Abstract: This disclosure relates to novel SARS-CoV-2 targeting sequences. Novel SARS-CoV-2 targeting oligonucleotides for the treatment of SARS-CoV-2 infection are also provided.
    Type: Application
    Filed: May 28, 2024
    Publication date: December 26, 2024
    Inventors: Anastasia Khvorova, Jonathan Watts, Zachary Kennedy, Annabelle Biscans, Bruno Miguel da Cruz Godinho, Chantal Ferguson, Dimas Echeverria Moreno, Ken Yamada, Daniel O'Reilly, Kathryn Monopoli, Vignesh Narayan Hariharan, Qi Tang, Sarah Davis, Samuel Hildebrand, Socheata Ly, Minwook Shin, Pranathi Meda Krishnamurthy, Nicholas McHugh, Jacquelyn Sousa, Jillian Caiazzi, Yann Thillier, Gitali Devi
  • OLIGONUCLEOTIDES FOR HTT-1A MODULATION
    Publication number: 20240301410
    Abstract: This disclosure relates to novel HTT-1A targeting sequences. Novel HTT-1A targeting oligonucleotides for the treatment of neurodegenerative diseases are also provided.
    Type: Application
    Filed: February 1, 2024
    Publication date: September 12, 2024
    Inventors: Anastasia Khvorova, Julia Alterman, Socheata Ly, Faith Conroy, Daniel O'Reilly, Sarah Allen
  • Oligonucleotides for SARS-CoV-2 modulation
    Patent number: 12077758
    Abstract: This disclosure relates to novel SARS-CoV-2 targeting sequences. Novel SARS-CoV-2 targeting oligonucleotides for the treatment of SARS-CoV-2 infection are also provided.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: September 3, 2024
    Assignee: UNIVERSITY OF MASSACHUSETTS
    Inventors: Anastasia Khvorova, Jonathan Watts, Zachary Kennedy, Annabelle Biscans, Bruno Miguel da Cruz Godinho, Chantal Ferguson, Dimas Echeverria Moreno, Ken Yamada, Daniel O′Reilly, Kathryn Monopoli, Vignesh Narayan Hariharan, Qi Tang, Sarah Davis, Samuel Hildebrand, Socheata Ly, Minwook Shin, Pranathi Meda Krishnamurthy, Nicholas McHugh, Jacquelyn Sousa, Jillian Caiazzi, Yann Thillier, Gitali Devi
  • METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
    Publication number: 20230364266
    Abstract: Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed.
    Type: Application
    Filed: May 5, 2023
    Publication date: November 16, 2023
    Inventors: Daniel GETTS, Yuxiao Wang, Namita Bisaria, Inna Shcherbakova, Socheata Ly
  • METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
    Publication number: 20230364265
    Abstract: Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed.
    Type: Application
    Filed: May 5, 2023
    Publication date: November 16, 2023
    Inventors: Daniel GETTS, Yuxiao Wang, Namita Bisaria, Inna Shcherbakova, Socheata Ly
  • Methods and compositions for genomic integration
    Patent number: 11672874
    Abstract: Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed.
    Type: Grant
    Filed: October 12, 2021
    Date of Patent: June 13, 2023
    Assignee: MYELOID THERAPEUTICS, INC.
    Inventors: Daniel Getts, Yuxiao Wang, Namita Bisaria, Inna Shcherbakova, Socheata Ly
  • METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
    Publication number: 20230141052
    Abstract: Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed.
    Type: Application
    Filed: January 19, 2023
    Publication date: May 11, 2023
    Inventors: Daniel Getts, Yuxiao Wang, Namita Bisaria, Inna Shcherbakova, Socheata Ly
  • METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
    Publication number: 20230067484
    Abstract: Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed.
    Type: Application
    Filed: October 12, 2021
    Publication date: March 2, 2023
    Inventors: Daniel GETTS, Yuxiao Wang, Namita Bisaria, Inna Shcherbakova, Socheata Ly
  • OLIGONUCLEOTIDES FOR SARS-CoV-2 MODULATION
    Publication number: 20230021431
    Abstract: This disclosure relates to novel SARS-CoV-2 targeting sequences. Novel SARS-CoV-2 targeting oligonucleotides for the treatment of SARS-CoV-2 infection are also provided.
    Type: Application
    Filed: May 28, 2021
    Publication date: January 26, 2023
    Inventors: Anastasia Khvorova, Jonathan Watts, Zachary Kennedy, Annabelle Biscans, Bruno Miguel da Cruz Godinho, Chantal Ferguson, Dimas Echeverria Moreno, Ken Yamada, Daniel O'Reilly, Kathryn Monopoli, Vignesh Narayan Hariharan, Qi Tang, Sarah Davis, Samuel Hildebrand, Socheata Ly, Minwook Shin, Pranathi Meda Krishnamurthy, Nicholas McHugh, Jacquelyn Sousa, Jillian Caiazzi, Yann Thillier, Gitali Devi
  • METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
    Publication number: 20220411817
    Abstract: Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed.
    Type: Application
    Filed: June 30, 2022
    Publication date: December 29, 2022
    Inventors: Daniel Getts, Yuxiao Wang, Namita Bisaria, Inna Shcherbakova, Socheata Ly
  • METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION
    Publication number: 20220364110
    Abstract: Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed.
    Type: Application
    Filed: June 30, 2022
    Publication date: November 17, 2022
    Inventors: Daniel Getts, Yuxiao Wang, Namita Bisaria, Inna Shcherbakova, Socheata Ly
  • OLIGONUCLEOTIDES FOR HTT-1A MODULATION
    Publication number: 20220090069
    Abstract: This disclosure relates to novel HTT-1A targeting sequences. Novel HTT-1A targeting oligonucleotides for the treatment of neurodegenerative diseases are also provided.
    Type: Application
    Filed: August 2, 2021
    Publication date: March 24, 2022
    Inventors: Anastasia Khvorova, Julia Alterman, Socheata Ly, Faith Conroy, Daniel O'Reilly